by Fluoroscopy devices such as C-arms, angiography systems, and mobile fluoroscopes play a crucial role in various surgical procedures by enabling real-time imaging, guiding instruments, and providing anatomical documentation. The seamless integration of fluoroscopy imaging systems with surgical equipment aids physicians to perform minimally-invasive surgeries effectively.
The global Fluoroscopy Devices Market is estimated to be valued at US$ 5437.8 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing preference for minimally-invasive procedures over traditional open surgeries has been a major driver for the fluoroscopy devices market. Minimally-invasive surgeries have various advantages such as smaller incisions, less pain, reduced scarring, shorter hospital stays, and faster recovery times. According to a report by Organisation for Economic Co-operation and Development (OECD), over 2 million minimally-invasive surgeries are performed annually in the US. With growing awareness about the benefits of minimally-invasive surgeries and technological advancements, the demand for fluoroscopy-guided procedures is expected to increase significantly during the forecast period.
SWOT Analysis
Strength: Fluoroscopy devices provide real-time imaging and enable minimally invasive procedures. This improves patient outcomes and reduces recovery time.
Weakness: Fluoroscopy devices emit ionizing radiation which can potentially cause health risks if not used properly. Regular staff training is required to minimize risks.
Opportunity: Rising preference for minimally invasive surgeries across various clinical areas provides growth opportunities.Growing geriatric population suffering from chronic diseases also contributes to market growth.
Threats: Stringent government regulations regarding approval and use of medical imaging devices pose challenges.High costs associated with fluoroscopy systems limit widespread adoption.
Key Takeaways
The Global Fluoroscopy Devices Market Size is expected to witness high growth. The global Fluoroscopy Devices Market is estimated to be valued at US$ 5437.8 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031.
North America region currently dominates the market and the trend is expected to continue during the forecast period. This is attributed to wider reimbursement coverage and increasing adoption of minimally invasive surgeries. Asia Pacific region is expected to witness fastest CAGR over the forecast period owing to rising healthcare expenditure, increasing patient volume and growing medical tourism.
Key players related content comprises:
Key players operating in the Fluoroscopy Devices market are Kemira Oyj, ION EXCHANGE (I) Ltd, Thermax Ltd, BASF-SE, GE Water & Process Technologies, Dorf Ketal, Chembond India Ltd, SNF Group, Vasu Chemicals, E. I. du Pont de Nemours and Company, Shandong Taihe Water Treatment Technologies Co., Ltd., and Shandong XinTai Water Treatment Technology Co., Ltd. These players are focusing on new product launches and geographical expansion to garner higher market share.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
